A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer.

NCT05493995 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Collaborators